Characteristics of LT recipients who experienced GVHD
| Patient No. | Recipient | Donor relation | Donor | HLA-OWMM | GVHD diagnosis (day) | Diagnostic method | IS discontinuation | Steroid pulse | Mortality due to GVHD | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (yr) | Sex | Age (yr) | Sex | ||||||||
| 1 | 41 | M | Deceased | 41 | M | No | 18 | Skin Bx | No | Yes | Death |
| 2 | 59 | M | Deceased | 51 | F | No | 19 | Skin Bx | No | Yes | Death |
| 3 | 50 | F | Deceased | 22 | M | No | 16 | Skin Bx | No | Yes | Death |
| 4 | 57 | M | Offspring | 31 | F | No | 16 | Skin Bx | Yes | Yes | Death |
| 5 | 55 | F | Deceased | 40 | F | No | 24 | Skin Bx | Yes | Yes | Death |
| 6 | 56 | M | Deceased | 54 | F | No | 17 | Skin Bx | No | Yes | Death |
| 7 | 2 | M | Relative | 35 | F | No | 34 | Skin Bx | No | Yes | Death |
| 8 | 51 | M | Offspring | 20 | M | No | 21 | Skin Bx | No | Yes | Survived |
| 9 | 61 | F | Deceased | 54 | M | No | 13 | Skin Bx | No | Yes | Survived |
| 10 | 51 | M | Offspring | 17 | M | No | 17 | Skin Bx | Yes | Yes | Death |
| 11 | 55 | M | Deceased | 48 | M | No | 11 | Skin Bx | Yes | Yes | Death |
| 12 | 64 | M | Offspring | 34 | M | 3 Loci | 16 | Skin Bx | No | Yes | Death |
| 13 | 48 | M | Offspring | 17 | M | 1–2 Loci | 65 | Skin Bx | Yes | Yes | Death |
| 14 | 57 | M | Offspring | 36 | M | No | 15 | HLA chimerism | Yes | Yes | Death |
| 15 | 64 | M | Offspring | 28 | F | No | 16 | Colonoscopic Bx | Yes | Yes | Survived |
LT, liver transplantation; GVHD, graft-versus-host disease; HLA, human leukocyte antigen; OWMM, one-way mismatch; IS, Immunosuppressant; Bx, biopsy.